Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Dosch

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2008
Pancreatic cancer stem cellsCheong J Lee, Joseph Dosch, Diane M Simeone
Gastroenterology|September 28, 2011
c-Met is a marker of pancreatic cancer stem cells and therapeutic targetChenwei Li, Jing-Jiang Wu, Mark Hynes, et al.
Neoplasia (New York, N.Y.)|September 27, 2015
Modeling selective elimination of quiescent cancer cells from bone marrowStephen P Cavnar, Andrew D Rickelmann, Kaille F Meguiar, et al.
Oncotarget|October 15, 2017
Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequencyJoseph Dosch, Elizabeth Ziemke, Shanshan Wan, et al.
Science Signaling|January 8, 2015
The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signalingShyam Nyati, Katrina Schinske-Sebolt, Sethuramasundaram Pitchiaya, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2008
Pancreatic cancer stem cellsCheong J Lee, Joseph Dosch, Diane M Simeone
Gastroenterology|September 28, 2011
c-Met is a marker of pancreatic cancer stem cells and therapeutic targetChenwei Li, Jing-Jiang Wu, Mark Hynes, et al.
Neoplasia (New York, N.Y.)|September 27, 2015
Modeling selective elimination of quiescent cancer cells from bone marrowStephen P Cavnar, Andrew D Rickelmann, Kaille F Meguiar, et al.
Oncotarget|October 15, 2017
Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequencyJoseph Dosch, Elizabeth Ziemke, Shanshan Wan, et al.
Science Signaling|January 8, 2015
The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signalingShyam Nyati, Katrina Schinske-Sebolt, Sethuramasundaram Pitchiaya, et al.
Pageof 1